RankAlpha logo
Back to Rankings

AGEN

AgenusF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
AGEN vs peer average
19/100
AGEN vs. peer average (F vs. C)
Grade spread
A 3 · B 1 · C 2 · D 2 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

AARD is the first available peer comparator.

Aardvark Therapeutics is a packet-identified same-sector, similar-market-cap biotech comparator, but it should be used only as a small-cap clinical-development and financing-risk reference rather than as a direct BOT+BAL oncology peer.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerAARDAardvark Therapeutics
AGEN
Agenus
AARD
Aardvark Therapeutics
Grade
F
D
Momentum
99
91
Value
52
41
Sentiment
0
45
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs AARD

AGEN / AARD
Grade Position
Below peers
AGEN vs. peer average (F vs. C)
19/100
Momentum
99
AGEN
Value
52
AGEN
Sentiment
0
AARD

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs AGEN
1
AARD
AARD
D
40/100
-1
2
GNLX
GNLX
A
100/100
-4
3
GALT
GALT
C
60/100
-2
4
TLSI
TriSalus Life Sciences Inc Common
F
20/100
Even
5
VNDA
Vanda Pharmaceuticals Inc Common
A
100/100
-4
AARD is the first peer returned for this comparison set.